Aggressive daily interferon ther... [J Acquir Immune Defic Syndr. 2000] - PubMed

Related citations

Impact of HAART on liver histology of HIV/HCV coinfected patients. [J Biol Regul Homeost Agents. 2003]
Impact of HAART on liver histology of HIV/HCV coinfected patients.
De Bona A, Sitia G, Uberti-Foppa C, Galli L, Ciuffreda D, Gallotta G, Paties C, Lazzarin A. J Biol Regul Homeost Agents. 2003 Apr-Jun; 17(2):195-7.
Changes in hepatitis C virus (HCV) viral load and interferon-alpha levels in HIV/HCV-coinfected patients treated with highly active antiretroviral therapy. [J Acquir Immune Defic Syndr. 2006]
Changes in hepatitis C virus (HCV) viral load and interferon-alpha levels in HIV/HCV-coinfected patients treated with highly active antiretroviral therapy.
Bower WA, Culver DH, Castor D, Wu Y, James VN, Zheng H, Hammer S, Kuhnert WL, Williams IT, Bell BP, et al. J Acquir Immune Defic Syndr. 2006 Jul; 42(3):293-7.
Pilot study of interferon-alpha with and without amantadine for the treatment of hepatitis C in HIV coinfected individuals on antiretroviral therapy. [Infection. 2001]
Pilot study of interferon-alpha with and without amantadine for the treatment of hepatitis C in HIV coinfected individuals on antiretroviral therapy.
Sax H, Friedl A, Renner E, Steuerwald MH, Weber R, Swiss HIV Cohort Study. Infection. 2001 Oct; 29(5):267-70.
Review HIV and hepatitis C coinfection. [J Gastroenterol Hepatol. 2008]
Review HIV and hepatitis C coinfection.
Matthews GV, Dore GJ. J Gastroenterol Hepatol. 2008 Jul; 23(7 Pt 1):1000-8.
Review Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients. [AIDS. 2006]
Review Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients.
Dominguez S, Ghosn J, Valantin MA, Schruniger A, Simon A, Bonnard P, Caumes E, Pialoux G, Benhamou Y, Thibault V, et al. AIDS. 2006 May 12; 20(8):1157-61.

See reviews... See all...

Cited by 1 PubMed Central article

Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C. [BMC Infect Dis. 2002]
Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C.
Bruno R, Sacchi P, Puoti M, Ciappina V, Zocchetti C, Brunetti E, Maffezzini E, Capelli A, Patruno SF, Malfitano A, et al. BMC Infect Dis. 2002 Aug 28; 2:17. Epub 2002 Aug 28.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Aggressive daily interferon therapy in HIV-HCV coinfected patients.
Aggressive daily interferon therapy in HIV-HCV coinfected patients.
J Acquir Immune Defic Syndr. 2000 Dec 1 ;25(4):372-3.

PubMed
Comparative analysis of six different antibodies against Her2 including the nove...
Comparative analysis of six different antibodies against Her2 including the novel rabbit monoclonal antibody (SP3) and chromogenic in situ hybridisation in breast carcinomas.
J Clin Pathol. 2008 Aug ;61(8):934-8. Epub 2008 May 12 .

PubMed
Community variation: disparities in health care quality between Asian and white ...
Community variation: disparities in health care quality between Asian and white medicare beneficiaries.
Health Aff (Millwood). 2008 Mar-Apr ;27(2):538-49.

PubMed
Spectrum of endoscopic findings and therapy in patients with upper gastrointesti...
Spectrum of endoscopic findings and therapy in patients with upper gastrointestinal symptoms after laparoscopic bariatric surgery.
Obes Surg. 2006 Sep ;16(9):1232-7.

PubMed
Nucleotide excision repair polymorphisms may modify ionizing radiation-related b...
Nucleotide excision repair polymorphisms may modify ionizing radiation-related breast cancer risk in US radiologic technologists.
Int J Cancer. 2008 Dec 1 ;123(11):2713-6.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Aggressive daily interferon therapy in HIV-HCV coinfected patients.

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Related citations

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information